Drugs / Co-artemether
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00233337 | May 2001 → Aug 2005 | Plasmodium falciparum malaria | Novartis Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Co-artemether | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00233337 ↗ |